|
|
|
|
NARFE November 2025
November is National Family Caregivers Month, and we're recognizing the millions of family members and friends who care for loved ones living with Alzheimer's or another dementia. Caregiving is a journey that no one should navigate alone. Whether you're providing daily support, helping with decisions or simply showing you care, the Alzheimer's Association® is here with resources like our 24/7 Helpline (800.272.3900) and caregiving tools at alz.org/care. Your partnership makes these resources possible, and we are deeply grateful for our NARFE community. Thank you for your continued commitment to ending Alzheimer's!
|
|
|
First blood test approved to rule out Alzheimer's-related amyloid pathology
The U.S. Food and Drug Administration approved the Eleusis pTau181 plasma test, the first blood-based biomarker test cleared for use in the primary care setting specifically to rule out Alzheimer's-related amyloid pathology. The Alzheimer's Association believes this approval is another important step toward expanding access to Alzheimer's disease diagnostic tools but cautions the test won't provide a diagnosis, nor is it a standalone tool for detection. Learn more.
|
|
|
|
|
Respite care may help Alzheimer's caregivers recharge
Respite care provides caregivers a temporary break while a person living with Alzheimer's continues to receive care in a safe environment. Using respite services can support and strengthen your ability to be a caregiver. Learn more.
|
|
|
|
|
GLP-1s and Alzheimer's: What you need to know
A class of drugs called GLP-1 receptor agonists — widely known for treating type 2 diabetes and obesity — has gained attention for a surprising new possibility: helping to treat Alzheimer's disease. On our blog, learn how the upcoming findings of two clinical trials could represent a pivotal moment for Alzheimer's care, shaping how the disease is treated and managed. Learn more.
|
|
|
|
|
It may be difficult to tell symptoms of Alzheimer's and depression apart
Depression is common among people living with Alzheimer's, especially during the early and middle stages. Identifying depression in someone living with the disease can be difficult since the conditions share similar symptoms. Learn more.
|
|
|
|
|
View Past Issues
|
|
|
|
|
NARFE 2026 Goal: $17 Million
|
|
|
|
24/7 Helpline: 1-800-272-3900
|
|
